Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
ac, ANCHOR, Andover, anufacturing, ass, Australia, beg, Brazil, Carrier, CMS, constant, correction, counting, covorin, de, dependi, des, disclaim, distrib, division, ECG, emplo, er, erall, ged, GELA, innovation, ird, judgement, Justice, lot, lytic, malfunction, MCRC, meaningful, Mexico, NCA, ng, NSCLC, ognize, osition, ot, oth, ov, pancreatic, pathway, pled, priority, published, rebuild, rec, reimbu, repurch, retroactive, science, shifted, standard, subpoena, substance, supplement, supplemental, Supreme, thrombo, ue, unapproved, urrently, val, vi, workshop
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.22 1999 Stock Plan, Form of Stock Option Agreement.
- 10.23 1999 Stock Plan, Form of Stock Option Agreement (Director Version).
- 10.24 Promissory Note, Dated As of April 5, 2001, Issued to Genentech, Inc. by Richard H. Scheller.
- 15.1 Letter Regarding Unaudited Interim Financial Information.
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended.
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended.
- 32.1 Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
- PDF "Unofficial" PDF Copy of Form 10-Q (September 30, 2004)
Genentech similar filings
External links